BioSpace News Archive

Biotech Bay

Vera Therapeutics Presents Phase 2a Data Showing Atacicept Reduces Serum Gd-IgA1 in Patients with IgA Nephropathy at the American Society of Nephrology Kidney Week 2021

Vera Therapeutics, Inc. today presented clinical data for the Company’s lead product candidate, atacicept, from the Phase 2a JANUS clinical trial in patients with IgA nephropathy (IgAN) at the American Society of Nephrology Kidney Week 2021 Annual Meeting held virtually November 4-7, 2021.

November 4, 2021
·
5 min read
Business

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

November 4, 2021
·
11 min read
Business

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2021 Financial Results

Aligos Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, reported recent business progress and financial results for the third quarter ended, September 30, 2021.

November 4, 2021
·
9 min read
Business

electroCore Announces Third Quarter 2021 Financial Results

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced third quarter 2021 financial results and provided an operational update.

November 4, 2021
·
14 min read
Biotech Bay

HeartFlow Holding, Inc. to Participate in Upcoming Virtual Investor Conferences

HeartFlow Holding, Inc ., the leader in revolutionizing precision heart care, today announced the company will be participating in two upcoming virtual investor conferences.

November 4, 2021
·
1 min read
Business

Sensus Healthcare Reports Third Quarter 2021 Financial Results

Sensus Healthcare, Inc. announces financial results for the three and nine months ended September 30, 2021.

November 4, 2021
·
16 min read
Business

Kura Oncology Reports Third Quarter 2021 Financial Results

Kura Oncology, Inc. today reported third quarter 2021 financial results and provided a corporate update.

November 4, 2021
·
10 min read
Business

Apria Announces Financial Results for Third Quarter 2021

Apria, Inc., a leading provider of integrated home healthcare equipment and related services in the United States, announced financial results for the third quarter ended September 30, 2021.

November 4, 2021
·
12 min read
Biotech Beach

Viracta Therapeutics Announces Upcoming Oral and Poster Presentations at the 2021 American Society of Hematology Annual Meeting

Viracta Therapeutics, Inc. today announced the acceptance of two abstracts for oral presentation and one for a poster presentation at the upcoming 2021 American Society of Hematology (ASH) Annual Meeting, which will be held from December 11-14, 2021, both in Atlanta, Georgia and virtually.

November 4, 2021
·
6 min read
Pharm Country

Aruvant Announces ARU-1801 Data to be Presented at the 63rd American Society of Hematology (ASH) Annual Meeting

Aruvant Sciences announced that an abstract demonstrating the clinical benefit of the company’s lead product candidate ARU-1801 has been published online and will be the subject of a poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition.

November 4, 2021
·
3 min read